| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/13/2008 | EP1885852A2 Methods and compositions for detecting immune responses |
| 02/13/2008 | EP1885851A1 Methods for diagnosing epigenetic, transgenerational effects of environmental toxicants on mammalian germ-lines and treating associated diseases |
| 02/13/2008 | EP1885850A1 D-psicose production method by d-psicose epimerase |
| 02/13/2008 | EP1885848A1 Microbial conversion of sugar acids and means useful therein |
| 02/13/2008 | EP1885842A2 Genetically modified yeast of the species issatchenkia orientalis and closely related species and fermentation processes using same |
| 02/13/2008 | EP1885754A2 T cell receptors which specifically bind to vygfvracl-hla-a24 |
| 02/13/2008 | EP1885751A1 Bone morphogenetic proteins containing a heparin binding site and osteogenic devices and pharmaceutical products containing thereof |
| 02/13/2008 | EP1885749A1 Bone morphogenetic protein 3 and osteogenic devices and pharmaceutical products containing thereof |
| 02/13/2008 | EP1885745A2 Use of h11 protein in in vitro diagnosis of streptococcus pyogenes infections |
| 02/13/2008 | EP1885739A2 Method of inhibiting intimal hyperplasia |
| 02/13/2008 | EP1885393A2 Methods and compositions for immunizing against chlamydia infection |
| 02/13/2008 | EP1885186A2 Method of targeted gene delivery using viral vectors |
| 02/13/2008 | EP1885175A2 Elevation of oil in monocot plants |
| 02/13/2008 | EP1885173A2 Chloroplasts engineered to express pharmaceutical proteins |
| 02/13/2008 | EP1745153A4 Processing polynucleotide-containing samples |
| 02/13/2008 | EP1711517A4 MUTANT SODIUM CHANNEL NAv1.7 AND METHODS RELATED THERETO |
| 02/13/2008 | EP1668126B1 Method for in vitro evolution of polypeptides |
| 02/13/2008 | EP1641483B1 Fusion proteins |
| 02/13/2008 | EP1631659A4 Modulation of the rna interference pathway |
| 02/13/2008 | EP1578915A4 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof |
| 02/13/2008 | EP1554401B1 Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture |
| 02/13/2008 | EP1543109B1 Substances for preventing and treating autoimmune diseases |
| 02/13/2008 | EP1517699B1 Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation |
| 02/13/2008 | EP1470148A4 Double-stranded oligonucleotides |
| 02/13/2008 | EP1465913A4 Heteroconfigurational polynucleotide and methods of use |
| 02/13/2008 | EP1461425B1 Novel human hydroxylases and polynucleotides encoding the same |
| 02/13/2008 | EP1451332B1 Production of eukaryotic proteins and nucleic acid molecules in c. elegans |
| 02/13/2008 | EP1407024B1 Process for the preparation of l-threonine using strains of the enterobacteriaceae family which contain an enhanced phoe gene |
| 02/13/2008 | EP1292328B1 Chimeric human papillomavirus (hpv) l1 molecules and uses therefor |
| 02/13/2008 | EP1272643B1 Talaromyces emersonii beta-glucanases |
| 02/13/2008 | EP1248646B1 Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another enteric pathogen |
| 02/13/2008 | EP1242602B1 Protein expression systems in non-pathogenic kinetoplastidae |
| 02/13/2008 | EP1220892B1 Engineering of metabolic control |
| 02/13/2008 | EP1212460B1 Methods and reagents for in situ amplification |
| 02/13/2008 | EP1207200B1 High affinity choline transporter |
| 02/13/2008 | EP1185663B1 Novel gbv sequence |
| 02/13/2008 | EP1177318B1 Polynucleotide matrix-based method of identifying microorganisms |
| 02/13/2008 | EP1171617B1 Enhancement of the immune response for vaccine and gene therapy applications |
| 02/13/2008 | EP1124973B1 Antibody-mediated down-regulation of plant proteins |
| 02/13/2008 | EP1104490B8 Method of detecting a dna sequence, a dna sequence, a method of making a dna construct and the use thereof |
| 02/13/2008 | EP1082126B1 Novel peptides |
| 02/13/2008 | EP1078069B1 Improved in vivo production of cephalosporins |
| 02/13/2008 | EP1068350B1 Directed antisense libraries |
| 02/13/2008 | EP1068294B1 Microbial strains and processes for the manufacture of biomaterials |
| 02/13/2008 | EP1005549B1 Prostate tumor polynucleotide and antigen compositions |
| 02/13/2008 | EP0946711B1 Improved expression vectors |
| 02/13/2008 | EP0843731B1 Adenovirus vectors for gene therapy |
| 02/13/2008 | EP0837928B1 Recombinant poxvirus - cytomegalovirus compositions and uses |
| 02/13/2008 | EP0820509B1 Genes encoding lymphocyte interferon regulatory factor (lsirf) polypeptides |
| 02/13/2008 | EP0797662B1 Methods for treatment or diagnosis of diseases or conditions associated with abnormal signal transduction |
| 02/13/2008 | EP0770138B1 Mycobacteria functional screening and/or expression vectors |
| 02/13/2008 | EP0764202B1 EXPRESSION PLASMIDS REGULATED BY AN osmB PROMOTER |
| 02/13/2008 | EP0755454B1 Aav-mediated delivery of dna to cells of the nervous system |
| 02/13/2008 | CN101124341A Method of identifying gene with variable expression |
| 02/13/2008 | CN101124339A Compositions and methods for modulating gene expression using self-protected oligonucleotides |
| 02/13/2008 | CN101124328A Chimeric vectors |
| 02/13/2008 | CN101124327A Modified CEA/B7 vector |
| 02/13/2008 | CN101124326A Transgenic evaluation of activated mutant alleles of SOS2 reveals a critical requirement for salt tolerance in arabidopsis thaliana |
| 02/13/2008 | CN101124325A Regulator for flowering time, transgenic plant transformed with the same, and method for regulating flowering time |
| 02/13/2008 | CN101124324A Genes conferring herbicide resistance |
| 02/13/2008 | CN101124323A Methods of protecting plants from pathogenic fungi |
| 02/13/2008 | CN101124322A RNAi inhibition of serum amyloid A for treatment of glaucoma |
| 02/13/2008 | CN101124321A Compositions and methods for purifying nucleic acids from stabilization reagents |
| 02/13/2008 | CN101124245A Neonatal Fc receptor (FcRn)-binding polypeptide variants, dimeric Fc binding proteins and methods related thereto |
| 02/13/2008 | CN101124244A Human monoclonal antibodies against CD25 |
| 02/13/2008 | CN101124242A Novel genes involved in gluconeogenesis |
| 02/13/2008 | CN101124241A Lawsonia intracellularis 26 kd subunit vaccine |
| 02/13/2008 | CN101124237A Surface proteins of streptococcus pyogenes |
| 02/13/2008 | CN101123994A Therapeutic uses of inhibitors of rtp801 |
| 02/13/2008 | CN101123993A Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation |
| 02/13/2008 | CN101123981A Improved DNA immunization with recombinase/transposase |
| 02/13/2008 | CN101123972A Methods for protein production |
| 02/13/2008 | CN101123871A Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production |
| 02/13/2008 | CN101123870A Isolated polypeptides and polynucleotides encoding same for generating plants with increased cuticlar water permeability |
| 02/13/2008 | CN101123869A Biological gene transfer system for eukaryotic cells |
| 02/13/2008 | CN101123868A Novel maize split-seed explant and methods for in vitro regeneration of maize |
| 02/13/2008 | CN101121945A Special RAPD molecule marker for wheat 6VS |
| 02/13/2008 | CN101121942A Corn genetic transferring method conducted by agrobacterium rhizogenes |
| 02/13/2008 | CN101121941A Method for producing salidroside by using agrobacterium rhizogenes to inherit and transfer rhodiola sachdlinensis and constructing capillaceous root cultural system |
| 02/13/2008 | CN101121940A Method for conversing switchgrass conducted by agrobacterium |
| 02/13/2008 | CN101121939A Universal green fluorescence protein fusion target gene expression carrier for siRNA screening system |
| 02/13/2008 | CN101121938A Method for preparing foot-and-mouth disease antigen |
| 02/13/2008 | CN101121937A Colibacillus gene engineering bacterin K88-K99-LT for firstborn piglet diarrhea and construction method thereof |
| 02/13/2008 | CN101121936A Colibacillus gene engineering bacterin 987P-ST-F41 for firstborn piglet diarrhea and construction method thereof |
| 02/13/2008 | CN101121935A Chlamys farreri serine protease inhibitor CfKZSPI gene and its coding protein and application |
| 02/13/2008 | CN101121934A Multiple target points miRNA antisense nucleic acid technique |
| 02/13/2008 | CN101121933A SiRNA used for kinase gene overexpression related disease |
| 02/13/2008 | CN101121932A Method for preparing phycocyanin fluorescence protein |
| 02/13/2008 | CN101121931A Method for preparing phycoerythrocyanin fluorescence protein |
| 02/13/2008 | CN101121925A Strain for producing arginine deiminase and application thereof |
| 02/13/2008 | CN101121753A Human serum albumin recombination fusion protein with continuous repairing function to multifarious skin cell |
| 02/13/2008 | CN101121752A Short peptide fusion expression heat induced recombinant plasmid using streptavidin as carrier and preparation method thereof |
| 02/13/2008 | CN101121751A PTD-tyrosine hydroxylase catalysis region fusion protein and application thereof |
| 02/13/2008 | CN101121749A Gamma-1 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 02/13/2008 | CN101121746A Jasmonic acid induced protein related to resistance of plant disease invasion and its coding gene and application |
| 02/13/2008 | CN101121023A Polynucleotide vaccine formula for treating porcine respiratory and reproductive diseases |
| 02/13/2008 | CN101120660A Method for inducing female nucleus growth with heterologous frozen sperm |
| 02/13/2008 | CN100369181C Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 02/13/2008 | CN100368564C Primer, method and kit for identifying PGC-1 gene promotor 1998 point SNP molecular mark |
| 02/13/2008 | CN100368563C Primer, method and kit for identifying PGC-1 gene promotor 2119 point SNP molecular mark |